Answers are grounded in this paper and cite their sources.
ABSTRACT tRNA‐derived small RNAs (tsRNAs) are an emerging class of regulatory non‐coding RNAs involved in diverse biological processes, yet their functions in the nucleus remain poorly understood. Here, we identify a nuclear‐enriched tsRNA, tsRNA‐076, that is markedly upregulated in synthetic vascular smooth muscle cells (VSMCs) and plays an important role in vascular remodeling. Mechanistically, tsRNA‐076 functions as an endogenous small activating RNA (saRNA) by directly associating with the IGF2BP2 (insulin‐like growth factor 2 mRNA binding protein 2) promoter and facilitating recruitment of the transcription factor ETV2 (ETS variant transcription factor 2), thereby driving transcriptional activation of IGF2BP2 . Elevated IGF2BP2 enhances ATG5 expression by stabilizing its mRNA in an m 6 A‐dependent manner, thereby promoting VSMC autophagy. Inhibition of tsRNA‐076 attenuates VSMC autophagy and alleviates vascular remodeling in vitro and in vivo. Together, these findings uncover a previously unrecognized RNA activation mechanism mediated by tsRNA‐076 and provide new insights into vascular remodeling.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: